Source: by Kyle Becker
The US Food and Drug Administration on Monday authorized a booster shot of Pfizer’s COVID-19 vaccine for children ages 12 to 15. The FDA also authorized a Pfizer booster for immunocompromised children ages 5 to 11. This would include those who’ve had an organ transplant or an underlying health condition that would prevent further
TRENDING: The Term ‘Mass Formation Psychosis’ is Now BANNED by Google Following Bombshell Dr. Malone Interview
The FDA also shortened the time all people need to wait between getting their second dose of Pfizer and booster shot to five months instead of the currently recommended six months. While this change applies only to Pfizer’s vaccine, the FDA said in a news release, the agency will continue to review data on all available COVID-19 vaccines and “provide additional updates as appropriate.”
